Pfizer buys promising drugmaker
Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions such as Crohn's disease but has no products on the market. |!| Fort Way…
Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions such as Crohn's disease but has no products on the market. |!| Fort Way…